OKUR — Onkure Therapeutics Share News
0.000.00%
Last trade - 00:00- $102.05m
- -$74.34m
Reneo Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Peloton, New Fortress Energy, Qualcomm
U.S. STOCKS ON THE MOVE-Paramount Global, First Horizon, Soligenix
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, Moderna, Shopify
U.S. STOCKS ON THE MOVE-Arconic, Wayfair, PacWest Bancorp
Reneo Pharma drops on pricing stock offering
Brief: Reneo Announces Pricing Of Public Offering 6.88 Million Common Shares Priced At $8.00 Per Share
Brief: Reneo Pharmaceuticals Expects To Report That It Had About $93.8 Million Of Cash, Cash Equivalents And Short-Term Investments
Brief: Reneo Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Brief: Reneo Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Brief: Reneo Pharmaceuticals Reports Q4 Loss Per Share Of $0.56
Reneo Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview
Reneo Pharma up as genetic disorder therapy trial achieves target enrollment
Brief: Reneo Pharmaceuticals Achieves Target Enrollment
Brief: Reneo Pharmaceuticals Inc Maintains Operating Accounts At SVB With Minimal Cash Balance
Brief: Reneo Pharmaceuticals Receives Fast Track Designation From The FDA For Mavodelpar
Reneo Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Reneo Pharmaceuticals Reports Third Quarter Results
Reneo Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview